Back

Results - Announcements

Sales rise 4.79% to Rs 974.37 crore

Glaxosmithkline Pharmaceuticals consolidated net profit rises 35.17% in the March 2025 quarter

14-May-2025, 07:27
Net profit of Glaxosmithkline Pharmaceuticals rose 35.17% to Rs 262.87 crore in the quarter ended March 2025 as against Rs 194.48 crore during the previous quarter ended March 2024. Sales rose 4.79% to Rs 974.37 crore in the quarter ended March 2025 as against Rs 929.80 crore during the previous quarter ended March 2024.

For the full year,net profit rose 57.23% to Rs 927.58 crore in the year ended March 2025 as against Rs 589.96 crore during the previous year ended March 2024. Sales rose 8.56% to Rs 3749.21 crore in the year ended March 2025 as against Rs 3453.71 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	974.37	929.80	5	3749.21	3453.71	9
OPM %	34.20	27.67	-	31.40	26.31	-
PBDT	373.29	286.32	30	1321.98	1029.48	28
PBT	358.57	268.22	34	1255.19	959.80	31
NP	262.87	194.48	35	927.58	589.96	57